The first trial in humans of the precise gene-editing technique known as base editing, by using the CRISPR–Cas9 machinery, has shown promising results for keeping cholesterol levels in check. The…
The first trial in humans of the precise gene-editing technique known as base editing, by using the CRISPR–Cas9 machinery, has shown promising results for keeping cholesterol levels in check. The…